Trials / Completed
CompletedNCT03559972
Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections
Open-Label, Randomized, Multi-center Study to Evaluate the Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Allergan · Industry
- Sex
- Female
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the efficacy and tolerability of two topical regimens (containing cosmetic human fibroblast-derived, physiologically-balanced growth factor combination products (HULK and TNS Essential Serum)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | on-label facial injection | Assessing if adding SkinMedica's cosmetic topical skincare regimens improves the appearance of the skin and the subject's experience, when used after pre-elected on-label facial injection |
Timeline
- Start date
- 2018-06-04
- Primary completion
- 2018-12-03
- Completion
- 2018-12-03
- First posted
- 2018-06-18
- Last updated
- 2019-01-30
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03559972. Inclusion in this directory is not an endorsement.